Rhesus macaque EGF R Protein, His Tag

English Name	Research Code	Research Phase	Company	First Brand Name	First Approved Country	First Indication	First Approved Company	First Approved Date	Indications	Clinical Trials
Cetuximab biosimilar (CinnaGen)		Approved	Cinnagen		Iran	Colorectal Neoplasms	Cinnagen	2017-01-01	Colorectal Neoplasms	Details
Olmutinib	ZL-2303; HM-61713; HM-61713B; BI-1482694	Approved	Hanmi Pharmaceutical Co Ltd	Olita	South Korea	Carcinoma, Non-Small-Cell Lung	Hanmi Pharmaceutical Co Ltd	2016-05-01	Carcinoma, Non-Small-Cell Lung	Details
Recombinant epidermal growth factor (Shanghai Haohai )		Approved	Shanghai Haohai Biological Technology Co Ltd	康合素	Mainland China	Burns	Shanghai Haohai Biological Technology Co Ltd	2001-01-01	Burns	Details
Cetuximab sarotalocan	RM-1929; ASP-1929	Approved	Aspyrian Therapeutics	Akalux	Japan	Head and Neck Neoplasms	Rakuten Medical	2020-09-25	Head and Neck Neoplasms	Details
Dacomitinib	PF-299; PF-804; PF-299804; PF-00299804; PF-00299804-3; PF-00299804-03	Approved	Pfizer Inc	Vizimpro	Mainland China	Carcinoma, Non-Small-Cell Lung	Pfizer Europe Ma Eeig	2018-09-27	Head and Neck Neoplasms; Solid tumours; Neoplasms; Liver Diseases; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis	Details
Neratinib Maleate	CAN-030; PB-272; HKI-272; PF-0528767; WAY-179272	Approved	Pfizer Pharmaceuticals Ltd (China)	Nerlynx	Mainland China	Breast Neoplasms	Excella Gmbh & Co Kg	2017-07-17	Solid tumours; Breast Neoplasms; Hepatic Insufficiency; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
Panitumumab	ABX-0303; E7.6.3; AMG-954; ABX-EGF; ABX-10221	Approved	Amgen Inc	Vectibix	Japan	Colorectal Neoplasms	Takeda	2006-09-27	Solid tumours; Head and Neck Neoplasms; Carcinoma; Carcinoma, Renal Cell; Rectal Neoplasms; Esophageal Neoplasms; Colonic Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Colorectal Neoplasms; Carcinoma, Squamous Cell; Lung Neoplasms; Gastrointestinal Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis	Details
Erlotinib Hydrochloride	R-1415; OSI-774; RG-1415; CP-358774; NSC-718781; RO-0508231; CP-358774-01	Approved	Genentech Inc	特罗凯, Tarceva	Japan	Carcinoma, Non-Small-Cell Lung	Chugai Pharmaceutical Co Ltd	2004-11-18	Head and Neck Neoplasms; Ependymoma; Solid tumours; Pancreatic Neoplasms; Glioblastoma; Breast Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
Nimotuzumab	h-R3; DE-766; KI-0501; KI-0502; OSAG-10; OSAG-101; YMB-1000; TheraCIMh-R3	Approved	Center Of Molecular Immunology	泰欣生, CIMAher, TheraCIM, Theraloc, BIOMAb-EGFR	Mainland China	Nasopharyngeal Neoplasms	Biotech Pharmaceuticals Co Ltd	2006-07-21	Head and Neck Neoplasms; Pancreatic Neoplasms; Nasopharyngeal Neoplasms; Carcinoma, Squamous Cell; Glioma; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms	Details
Cetuximab	C-255; ch-225; IMC-C255; BMS-564717; EMD-271786; GT-MAB-5.2; LY-2939777; NSC-714692	Approved	Bristol-Myers Squibb Company, Eli Lilly And Company, Merck Serono	爱必妥, Erbitux	Japan	Colorectal Neoplasms; Head and Neck Neoplasms	Merck Serono	2004-02-12	Head and Neck Neoplasms; Ovarian Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Colorectal Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung	Details
Lapatinib Ditosylate Hydrate	GW-2016; GW-572016; GW-572016F	Approved	Novartis Pharma Ag, Glaxosmithkline Plc	Tykerb/Tyverb, 泰立沙, Tykerb, Tyverb	Mainland China	Breast Neoplasms	Glaxosmithkline Ag	2007-03-13	Solid tumours; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Stomach Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Breast Diseases; Glioma; Gastrointestinal Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma	Details
Alflutinib Mesylate	AST-2818	Approved	Shanghai Allist Pharmaceutical Technology Co Ltd	艾弗沙	Mainland China	Carcinoma, Non-Small-Cell Lung	Shanghai Allist Pharmaceutical Technology Co Ltd	2021-03-02	Carcinoma, Non-Small-Cell Lung	Details
Gefitinib	ZD-1839	Approved	Astrazeneca Pharmaceutical Co Ltd	易瑞沙, Iressa	EU	Carcinoma, Non-Small-Cell Lung	Astrazeneca Ab	2002-07-05	Head and Neck Neoplasms; Carcinoma; Small Cell Lung Carcinoma; Glioblastoma; Mesothelioma; Prostatic Neoplasms; Breast Neoplasms; Brain Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Carcinoma, Squamous Cell; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung	Details
Afatinib Dimaleate	BIBW-2992; BIBW-2992-MA2	Approved	C.H. Boehringer Sohn Ag & Co. Kg	吉泰瑞, Tovok, Giotrif, Gilotrif, Tomtovok	Mainland China	Carcinoma, Non-Small-Cell Lung	Boehringer Ingelheim International Gmbh	2013-07-12	Head and Neck Neoplasms; Rhabdomyosarcoma; Squamous Cell Carcinoma of Head and Neck; Renal Insufficiency; Neoplasms; Neuroectodermal Tumors; Liver Diseases; Endometriosis; Breast Neoplasms; Colorectal Neoplasms; Urologic Neoplasms; Carcinoma, Squamous Cell; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma	Details
Brigatinib	AP-26113	Approved	Takeda Pharmaceutical Co Ltd, Ariad	Alunbrig	Japan	Carcinoma, Non-Small-Cell Lung	Takeda	2017-04-28	Solid tumours; Carcinoma; Myofibroma; Lymphoma, Large-Cell, Anaplastic; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
Necitumumab	IMC-11F8; LY-3012211	Approved	Eli Lilly And Company	Portrazza	Japan	Carcinoma, Non-Small-Cell Lung	Nippon Kayaku Co Ltd	2015-11-24	Solid tumours; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung	Details
Vandetanib	CH-331; ZD-6474; AZD-6474	Approved	Astrazeneca Pharmaceutical Co Ltd	Zactima, Caprelsa	Japan	Medullary thyroid cancer (MTC)	Astrazeneca Pharmaceutical Co Ltd	2011-04-06	Solid tumours; Multiple Myeloma; Mesothelioma; Medullary thyroid cancer (MTC); Prostatic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Thyroid Neoplasms; Lung Neoplasms; Carcinoma, Neuroendocrine; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular	Details
Osimertinib Mesylate	AZD9291; AZD-9291; RDL94R2A16; AZD-9291 Mesylate	Approved	Astrazeneca Pharmaceutical Co Ltd	泰瑞沙, Tagrisso	Mainland China	Carcinoma, Non-Small-Cell Lung	Astrazeneca Ab	2015-11-13	Solid tumours; Carcinoma; Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
Mouse epidermal growth factor (Hangzhou Tianmushan Pharmaceutical)		Approved	Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd	一夫					Wounds and Injuries	Details
Pyrotinib Maleate	HTI-1001; SHR-1258; BLTN	Approved	Jiangsu Hengrui Medicine Co Ltd	艾瑞妮	Mainland China	Breast Neoplasms	Jiangsu Hengrui Medicine Co Ltd	2018-08-12	Biliary Tract Neoplasms; Solid tumours; Stomach Neoplasms; Adenocarcinoma of Lung; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
Recombinant epidermal growth factor drop (Pavay Gene Pharmaceutical)		Approved	Guilin Huanuowei Gene Pharmaceutical Co Ltd	易贝	Mainland China	Corneal Diseases	Guilin Huanuowei Gene Pharmaceutical Co Ltd	2002-04-12	Corneal Diseases; Xerophthalmia	Details
Almonertinib Mesilate	HS-10296	Approved	Jiangsu Hansoh Pharmaceutical Group Co Ltd	阿美乐	Mainland China	Carcinoma, Non-Small-Cell Lung	Jiangsu Hansoh Pharmaceutical Group Co Ltd	2020-03-17	Carcinoma, Non-Small-Cell Lung	Details
Recombinant Human Epidermal Growth Factor Derivative Eye Drops (Shenzhen Wastin Genetech)		Approved	Shenzhen Watsin Genetech Ltd	金因舒, GeneSoft	Mainland China	Corneal Diseases	Shenzhen Watsin Genetech Ltd	2004-01-21	Corneal Diseases	Details
Recombinant epidermal growth factor biosimilar (Elea)	r-hu-EGF	Approved	Elea		Argentina	Diabetic Foot; Burns	Elea	2015-01-01	Diabetic Foot; Burns	Details
Recombinant epidermal growth factor (Bharat Biotech)	REGEN-D 60; REGEN-D 150	Approved	Bharat Biotech International Ltd		India	Diabetic Foot; Burns	Bharat Biotech International Ltd	2005-01-01	Diabetic Foot; Burns	Details
Recombinant human EGF conjugated vaccine		Approved	Biotech Pharmaceutical Co Ltd						Carcinoma, Non-Small-Cell Lung	Details
Icotinib Hydrochloride	BPI-2009H; BPI-2009C	Approved	Betta Pharmaceuticals Co Ltd	凯美纳, Conmana	Mainland China	Carcinoma, Non-Small-Cell Lung	Betta Pharmaceuticals Co Ltd	2011-06-07	Stomach Neoplasms; Esophageal Neoplasms; Psoriasis; Nasopharyngeal Carcinoma; Esophageal adenocarcinoma; Brain metastases; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma	Details
Nepidermin	DWP-401	Approved	Daewoong Pharmaceutical Co Ltd	Easyef	Egypt	Alopecia; Diabetic Foot	Daewoong Pharmaceutical Co Ltd	2001-01-01	Diabetic Foot; Alopecia	Details
Recombinant Human Epidermal Growth Factor Derivative For External Use,Liquid (Shenzhen Wastin Genetech)	rEGF	Approved	Shenzhen Watsin Genetech Ltd	金因肽, GeneTime	Mainland China	Wounds and Injuries	Shenzhen Watsin Genetech Ltd	2001-01-01	Wounds and Injuries	Details
Recombinant epidermal growth factor (Center for Genetic Engineering and Biotechnology/Praxis Pharmaceuticals)		Approved	Center For Genetic Engineering And Biotechnology, Praxis Pharmaceuticals	Heberprot-P	Cuba	Diabetic Foot	null	2007-09-01	Diabetic Foot	Details
Recombinant epidermal growth factor gel (Pavay Gene Pharmaceutical)		Approved	Guilin Huanuowei Gene Pharmaceutical Co Ltd	易孚	Mainland China	Skin Ulcer; Burns	Guilin Huanuowei Gene Pharmaceutical Co Ltd	2002-12-23	Skin Ulcer; Burns	Details
Epidermal growth factor biosimilar (RAS Lifesciences)		Approved	Ras Lifesciences		India		Ras Lifesciences	2012-10-01		Details

English Name

Research Code

Research Phase

Company

First Brand Name

First Approved Country

First Indication

First Approved Company

First Approved Date

Indications

Clinical Trials

Cetuximab biosimilar (CinnaGen)

Approved

Cinnagen

Iran

Colorectal Neoplasms

Cinnagen

2017-01-01

Colorectal Neoplasms

Details

Olmutinib

ZL-2303; HM-61713; HM-61713B; BI-1482694

Approved

Hanmi Pharmaceutical Co Ltd

Olita

South Korea

Carcinoma, Non-Small-Cell Lung

Hanmi Pharmaceutical Co Ltd

2016-05-01

Carcinoma, Non-Small-Cell Lung

Details

Recombinant epidermal growth factor (Shanghai Haohai )

Approved

Shanghai Haohai Biological Technology Co Ltd

康合素

Mainland China

Burns

Shanghai Haohai Biological Technology Co Ltd

2001-01-01

Burns

Details

Cetuximab sarotalocan

RM-1929; ASP-1929

Approved

Aspyrian Therapeutics

Akalux

Japan

Head and Neck Neoplasms

Rakuten Medical

2020-09-25

Head and Neck Neoplasms

Details

Dacomitinib

PF-299; PF-804; PF-299804; PF-00299804; PF-00299804-3; PF-00299804-03

Approved

Pfizer Inc

Vizimpro

Mainland China

Carcinoma, Non-Small-Cell Lung

Pfizer Europe Ma Eeig

2018-09-27

Head and Neck Neoplasms; Solid tumours; Neoplasms; Liver Diseases; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis

Details

Neratinib Maleate

CAN-030; PB-272; HKI-272; PF-0528767; WAY-179272

Approved

Pfizer Pharmaceuticals Ltd (China)

Nerlynx

Mainland China

Breast Neoplasms

Excella Gmbh & Co Kg

2017-07-17

Solid tumours; Breast Neoplasms; Hepatic Insufficiency; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung

Details

Panitumumab

ABX-0303; E7.6.3; AMG-954; ABX-EGF; ABX-10221

Approved

Amgen Inc

Vectibix

Japan

Colorectal Neoplasms

Takeda

2006-09-27

Solid tumours; Head and Neck Neoplasms; Carcinoma; Carcinoma, Renal Cell; Rectal Neoplasms; Esophageal Neoplasms; Colonic Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Colorectal Neoplasms; Carcinoma, Squamous Cell; Lung Neoplasms; Gastrointestinal Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis

Details

Erlotinib Hydrochloride

R-1415; OSI-774; RG-1415; CP-358774; NSC-718781; RO-0508231; CP-358774-01

Approved

Genentech Inc

特罗凯, Tarceva

Japan

Carcinoma, Non-Small-Cell Lung

Chugai Pharmaceutical Co Ltd

2004-11-18

Head and Neck Neoplasms; Ependymoma; Solid tumours; Pancreatic Neoplasms; Glioblastoma; Breast Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung

Details

Nimotuzumab

h-R3; DE-766; KI-0501; KI-0502; OSAG-10; OSAG-101; YMB-1000; TheraCIMh-R3

Approved

Center Of Molecular Immunology

泰欣生, CIMAher, TheraCIM, Theraloc, BIOMAb-EGFR

Mainland China

Nasopharyngeal Neoplasms

Biotech Pharmaceuticals Co Ltd

2006-07-21

Head and Neck Neoplasms; Pancreatic Neoplasms; Nasopharyngeal Neoplasms; Carcinoma, Squamous Cell; Glioma; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms

Details

Cetuximab

C-255; ch-225; IMC-C255; BMS-564717; EMD-271786; GT-MAB-5.2; LY-2939777; NSC-714692

Approved

Bristol-Myers Squibb Company, Eli Lilly And Company, Merck Serono

爱必妥, Erbitux

Japan

Colorectal Neoplasms; Head and Neck Neoplasms

Merck Serono

2004-02-12

Head and Neck Neoplasms; Ovarian Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Colorectal Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung

Details

Lapatinib Ditosylate Hydrate

GW-2016; GW-572016; GW-572016F

Approved

Novartis Pharma Ag, Glaxosmithkline Plc

Tykerb/Tyverb, 泰立沙, Tykerb, Tyverb

Mainland China

Breast Neoplasms

Glaxosmithkline Ag

2007-03-13

Solid tumours; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Stomach Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Breast Diseases; Glioma; Gastrointestinal Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma

Details

Alflutinib Mesylate

AST-2818

Approved

Shanghai Allist Pharmaceutical Technology Co Ltd

艾弗沙

Mainland China

Carcinoma, Non-Small-Cell Lung

Shanghai Allist Pharmaceutical Technology Co Ltd

2021-03-02

Carcinoma, Non-Small-Cell Lung

Details

Gefitinib

ZD-1839

Approved

Astrazeneca Pharmaceutical Co Ltd

易瑞沙, Iressa

Carcinoma, Non-Small-Cell Lung

Astrazeneca Ab

2002-07-05

Head and Neck Neoplasms; Carcinoma; Small Cell Lung Carcinoma; Glioblastoma; Mesothelioma; Prostatic Neoplasms; Breast Neoplasms; Brain Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Carcinoma, Squamous Cell; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung

Details

Afatinib Dimaleate

BIBW-2992; BIBW-2992-MA2

Approved

C.H. Boehringer Sohn Ag & Co. Kg

吉泰瑞, Tovok, Giotrif, Gilotrif, Tomtovok

Mainland China

Carcinoma, Non-Small-Cell Lung

Boehringer Ingelheim International Gmbh

2013-07-12

Head and Neck Neoplasms; Rhabdomyosarcoma; Squamous Cell Carcinoma of Head and Neck; Renal Insufficiency; Neoplasms; Neuroectodermal Tumors; Liver Diseases; Endometriosis; Breast Neoplasms; Colorectal Neoplasms; Urologic Neoplasms; Carcinoma, Squamous Cell; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma

Details

Brigatinib

AP-26113

Approved

Takeda Pharmaceutical Co Ltd, Ariad

Alunbrig

Japan

Carcinoma, Non-Small-Cell Lung

Takeda

2017-04-28

Solid tumours; Carcinoma; Myofibroma; Lymphoma, Large-Cell, Anaplastic; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung

Details

Necitumumab

IMC-11F8; LY-3012211

Approved

Eli Lilly And Company

Portrazza

Japan

Carcinoma, Non-Small-Cell Lung

Nippon Kayaku Co Ltd

2015-11-24

Solid tumours; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung

Details

Vandetanib

CH-331; ZD-6474; AZD-6474

Approved

Astrazeneca Pharmaceutical Co Ltd

Zactima, Caprelsa

Japan

Medullary thyroid cancer (MTC)

Astrazeneca Pharmaceutical Co Ltd

2011-04-06

Solid tumours; Multiple Myeloma; Mesothelioma; Medullary thyroid cancer (MTC); Prostatic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Thyroid Neoplasms; Lung Neoplasms; Carcinoma, Neuroendocrine; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular

Details

Osimertinib Mesylate

AZD9291; AZD-9291; RDL94R2A16; AZD-9291 Mesylate

Approved

Astrazeneca Pharmaceutical Co Ltd

泰瑞沙, Tagrisso

Mainland China

Carcinoma, Non-Small-Cell Lung

Astrazeneca Ab

2015-11-13

Solid tumours; Carcinoma; Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung

Details

Mouse epidermal growth factor (Hangzhou Tianmushan Pharmaceutical)

Approved

Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd

一夫

Wounds and Injuries

Details

Pyrotinib Maleate

HTI-1001; SHR-1258; BLTN

Approved

Jiangsu Hengrui Medicine Co Ltd

艾瑞妮

Mainland China

Breast Neoplasms

Jiangsu Hengrui Medicine Co Ltd

2018-08-12

Biliary Tract Neoplasms; Solid tumours; Stomach Neoplasms; Adenocarcinoma of Lung; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung

Details

Recombinant epidermal growth factor drop (Pavay Gene Pharmaceutical)

Approved

Guilin Huanuowei Gene Pharmaceutical Co Ltd

易贝

Mainland China

Corneal Diseases

Guilin Huanuowei Gene Pharmaceutical Co Ltd

2002-04-12

Corneal Diseases; Xerophthalmia

Details

Almonertinib Mesilate

HS-10296

Approved

Jiangsu Hansoh Pharmaceutical Group Co Ltd

阿美乐

Mainland China

Carcinoma, Non-Small-Cell Lung

Jiangsu Hansoh Pharmaceutical Group Co Ltd

2020-03-17

Carcinoma, Non-Small-Cell Lung

Details

Recombinant Human Epidermal Growth Factor Derivative Eye Drops (Shenzhen Wastin Genetech)

Approved

Shenzhen Watsin Genetech Ltd

金因舒, GeneSoft

Mainland China

Corneal Diseases

Shenzhen Watsin Genetech Ltd

2004-01-21

Corneal Diseases

Details

Recombinant epidermal growth factor biosimilar (Elea)

r-hu-EGF

Approved

Elea

Argentina

Diabetic Foot; Burns

Elea

2015-01-01

Diabetic Foot; Burns

Details

Recombinant epidermal growth factor (Bharat Biotech)

REGEN-D 60; REGEN-D 150

Approved

Bharat Biotech International Ltd

India

Diabetic Foot; Burns

Bharat Biotech International Ltd

2005-01-01

Diabetic Foot; Burns

Details

Recombinant human EGF conjugated vaccine

Approved

Biotech Pharmaceutical Co Ltd

Carcinoma, Non-Small-Cell Lung

Details

Icotinib Hydrochloride

BPI-2009H; BPI-2009C

Approved

Betta Pharmaceuticals Co Ltd

凯美纳, Conmana

Mainland China

Carcinoma, Non-Small-Cell Lung

Betta Pharmaceuticals Co Ltd

2011-06-07

Stomach Neoplasms; Esophageal Neoplasms; Psoriasis; Nasopharyngeal Carcinoma; Esophageal adenocarcinoma; Brain metastases; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma

Details

Nepidermin

DWP-401

Approved

Daewoong Pharmaceutical Co Ltd

Easyef

Egypt

Alopecia; Diabetic Foot

Daewoong Pharmaceutical Co Ltd

2001-01-01

Diabetic Foot; Alopecia

Details

Recombinant Human Epidermal Growth Factor Derivative For External Use,Liquid (Shenzhen Wastin Genetech)

rEGF

Approved

Shenzhen Watsin Genetech Ltd

金因肽, GeneTime

Mainland China

Wounds and Injuries

Shenzhen Watsin Genetech Ltd

2001-01-01

Wounds and Injuries

Details

Recombinant epidermal growth factor (Center for Genetic Engineering and Biotechnology/Praxis Pharmaceuticals)

Approved

Center For Genetic Engineering And Biotechnology, Praxis Pharmaceuticals

Heberprot-P

Cuba

Diabetic Foot

null

2007-09-01

Diabetic Foot

Details

Recombinant epidermal growth factor gel (Pavay Gene Pharmaceutical)

Approved

Guilin Huanuowei Gene Pharmaceutical Co Ltd

易孚

Mainland China

Skin Ulcer; Burns

Guilin Huanuowei Gene Pharmaceutical Co Ltd

2002-12-23

Skin Ulcer; Burns

Details

Epidermal growth factor biosimilar (RAS Lifesciences)

Approved

Ras Lifesciences

India

Ras Lifesciences

2012-10-01

Details

English Name	Research Code	Research Phase	Company	Indications	Clinical Trials
JMT101	JMT-101	Phase 1 Clinical	Shanghai Jinmante Biological Technology Co Ltd	Carcinoma, Non-Small-Cell Lung	Details
BBT-176	BBT-176	Phase 2 Clinical	Bridge Biotherapeutics	Carcinoma, Non-Small-Cell Lung	Details
Durvalumab/Gefitinib		Phase 2 Clinical	Medimmune	Carcinoma, Non-Small-Cell Lung	Details
Cetuximab biosimilar (Enzene Biosciences)		Clinical	Enzene Biosciences	Carcinoma, Squamous Cell	Details
Neptinib Di-P-methylbenzenesulfonate		Phase 1 Clinical	Shenzhen Neptune Pharmaceutical Technology Research Institute Co Ltd	Stomach Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
Pirotinib Hydrochloride	KBP-5209	Phase 2 Clinical	Shandong Xuanzhu Pharmaceutical Technology Co Ltd	Neoplasms; Breast Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
YZJ-0318 Maleate	YZJ-0318 Maleate	Phase 1 Clinical	Shanghai Haiyan, Yangtze River Pharmaceutical Group Jiangsu Haici Biological Pharmaceut Co Ltd	Carcinoma, Non-Small-Cell Lung	Details
Recombinant anti-EGFR chimeric antibody (Harbin Pharmaceutical)		Phase 1 Clinical	Harbin Pharmaceutical Group Holding Co Ltd	Colorectal Neoplasms	Details
BCA-101	BCA-101	Phase 1 Clinical	Bicara Therapeutics	Anus Neoplasms; Squamous Cell Carcinoma of Head and Neck; Thyroid Carcinoma, Anaplastic; Triple Negative Breast Neoplasms; Pancreatic Neoplasms; Glioblastoma; Carcinoma, Ovarian Epithelial; Neoplasms; Uveal melanoma; Chordoma; Colorectal Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Hepatocellular	Details
EGFRvIII-CAR		Phase 1 Clinical	Duke University Medical Center	Glioblastoma	Details
Recombinant anti-EGFR monoclonal antibody (Humanwell Healthcare)		Phase 1 Clinical	Humanwell Healthcare (Group) Co Ltd	Colorectal Neoplasms	Details
C-005	C-005	Phase 1 Clinical	Nanjing Galaxy Biopharma Co Ltd	Carcinoma, Non-Small-Cell Lung	Details
Anti-EGFR CAR-T cell therapy (Cellular Biomedicine Group)		Phase 2 Clinical	Cellular Biomedicine (Shanghai) Co Ltd, People'S Liberation Army General Hospital Military Service	Neoplasms	Details
Anti-CD3/anti-EGFR -activated T cells (Barbara Ann Karmanos Cancer Institute)		Phase 2 Clinical	Barbara Ann Karmanos Cancer Institute, University Of Virginia	Glioblastoma; Pancreatic Neoplasms	Details
Anti-EGFR-IL-dox (Swiss Group for Clinical Cancer Research)		Phase 2 Clinical	Schweizerische Arbeitsgemeinschaft Für Klinische Krebsforschung	Breast Neoplasms	Details
BB-101 (Blue Blood Biotech/National Cheng Kung University)	BB-101	Phase 1 Clinical	National Cheng Kung University, Blue Blood Biotech	Diabetic Foot	Details
NRC-2694	NRC-2694; NRC-2694A; NRC-2694-A	Phase 2 Clinical	Natco	Carcinoma, Squamous Cell	Details
Autologous EGFR-CAR T cells (Bio-gene)		Phase 1 Clinical	Sun Yat-Sen University, Guangzhou Baiji Gene Technology Co Ltd	Carcinoma, Non-Small-Cell Lung	Details
Tarloxotinib Bromide	PR-610; TH-4000; SN-33999	Phase 2 Clinical	Threshold	Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
C225-ILS-DOX	C225-ILs-dox	Phase 2 Clinical	Universitaetsspitals Basel	Breast Neoplasms	Details
E-EDV-D682	PNU-15982; E-EDV-D682; EGFR-EDV-PNU-15982	Phase 2 Clinical	Engeneic	Pancreatic Neoplasms	Details
MicroRNA encapsulated nanocells (EnGeneIC)		Phase 2 Clinical	Engeneic	Mesothelioma	Details
AFM-24	AFM-24	Phase 2 Clinical	Affimed	Neoplasms	Details
Cetuximab biosimilar (R-Pharm)	RPH-002	Phase 3 Clinical	R-Pharm	Head and Neck Neoplasms; Pancreatic Neoplasms	Details
14C-labeled poziotinib		Phase 1 Clinical	Spectrum Pharmaceuticals	Neoplasms	Details
Cetuximab biosimilar (AlphaMab)	KN-005	Phase 3 Clinical	Suzhou Alphamab Co Ltd	Head and Neck Neoplasms; Anus Neoplasms; Urinary Bladder Neoplasms; Colorectal Neoplasms	Details
AMX-3009 Maleate	AMX-3009; AMX3009马来酸	Phase 1 Clinical	Anrun Medicine Technology (Suzhou) Co Ltd	Solid tumours; Stomach Neoplasms; Pancreatic Neoplasms; Breast Neoplasms	Details
4-1BBz CD19-Her2tG (Seattle Children's Hospital)		Phase 1 Clinical	Seattle Children'S Hospital	Neoplasms	Details
Cetuximab biobetter (Glycotope)	GT-MAB-5.2-GEX	Phase 2 Clinical	Glycotope	Head and Neck Neoplasms; Carcinoma, Renal Cell; Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
Anti-EGFR-bispecific antibody armed activated T-cell therapy (Memorial Sloan Kettering Cancer Center)		Phase 1 Clinical	Memorial Sloan Kettering Cancer Center	Pancreatic Neoplasms	Details
HER-1 vaccine (Center of Molecular Immunology)	HER1-ECD; HER1-VSSP; HER-1-ECD-VSSP	Phase 2 Clinical	Center Of Molecular Immunology	Neoplasms	Details
Double-deleted Vaccinia Virus Plus CD/ SMR	JX-929; vvDD-CDSR	Phase 1 Clinical	Sillajen	Liver Neoplasms; Squamous Cell Carcinoma of Head and Neck; Pancreatic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Melanoma	Details
SGT-210	SGT-210	Phase 1 Clinical	Sol Gel Technologies Pte Ltd	Keratosis	Details
Futuximab/Modotuximab	Sym-004; 992-and-1024	Phase 3 Clinical	Symphogen	Carcinoma; Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms	Details
Pemlimogene merolisbac (Aduro Biotech/Jannsen Biotech)	ADU-214; JNJ-64041757	Phase 2 Clinical	Aduro Biotech	Ovarian Neoplasms; Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung	Details
MM-151	MM-151	Phase 2 Clinical	Merrimack	Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
EMB-01	EMB-01	Phase 2 Clinical	Shanghai Epimab Biotherapeutics, Inc	Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis	Details
D2C7-based immunotoxins (Duke University)	D2C7-IT; scds-D2C7 -PE38KDEL; D2C7-(scdsFv)-PE38 KDEL	Phase 1 Clinical	Istari Oncology, Duke University	Glioma	Details
PB-357	PB-357	Phase 1 Clinical	Pfizer Inc	Neoplasms	Details
Losatuxizumab vedotin	ABBV221; ABBV-221	Phase 1 Clinical	Abbvie Inc	Neoplasms	Details
Nimotuzumab biosimilar (El Kendi Pharmaceuticals Manufacturing)		Phase 3 Clinical	El Kendi Pharmaceuticals	Uterine Cervical Neoplasms	Details
TQB3804	TQB-3804	Phase 1 Clinical	Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd	Solid tumours; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung	Details
Recombinant anti-EGFR monoclonal antibody- DUO5 conjugate		Phase 1 Clinical	Zhejiang Hisun Pharmaceutical Co Ltd, Zhejiang Zhaohua Biomedicine Co Ltd	Neoplasms	Details
SI-B001	SI-B001	Phase 1 Clinical	Sichuan Baili Pharmaceutical Co Ltd	Carcinoma; Neoplasms, Glandular and Epithelial	Details
BB-401	BB-401	Phase 2 Clinical	Benitec Biopharma	Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck	Details
WSD-0922	WSD0922; WSD-0922	Phase 1 Clinical	Wayshine Biopharm	Glioblastoma; Glioma	Details
Doxitinib mesylate		Phase 2 Clinical	Henan Real Biotechnology Co Ltd	Carcinoma, Non-Small-Cell Lung	Details
Cetuximab biobetter (Mabtech/Sorrento)	STI-001	Phase 3 Clinical	Taizhou Maibo Taike Biotechnology Co Ltd, Shanghai Biomabs Pharmaceuticals Co Ltd	Colorectal Neoplasms	Details
Anti-EGFR CAR T-cell therapy (Seattle Children's Hospital)	EGFR-806	Phase 1 Clinical	Seattle Children'S Hospital	Central Nervous System Neoplasms	Details
Epertinib	S-222611	Phase 2 Clinical	Shionogi & Co Ltd	Neoplasms	Details
BEBT-109	BEBT-109	Phase 1 Clinical	Guangzhou Bibet Medical Technology Co Ltd	Carcinoma, Non-Small-Cell Lung	Details
KSP-QRH-E3-IRDye800		Phase 1 Clinical	University Of Michigan	Cholangiocarcinoma	Details
YK-029A	YK-029A	Phase 1 Clinical	Hainan Yuekang Biomedicine Co Ltd	Carcinoma, Non-Small-Cell Lung	Details
Entinostat/Erlotinib Hydrochloride		Phase 2 Clinical	Colorado State University Foundation, Syndax	Carcinoma, Non-Small-Cell Lung	Details
MP-0274	DARPin-41; SPA-28; CME-114; CME-115; CME-118; CME-119; MP-0274	Phase 1 Clinical	Molecular Partners Ag	Neoplasms	Details
DZD-9008	DZD-9008	Phase 2 Clinical	Dizal (Jiangsu) Pharmaceutical Co Ltd	Leukemia; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Lymphoma; Lymphoma, Non-Hodgkin; Carcinoma, Non-Small-Cell Lung	Details
ZSP0391	ZSP-0391	Phase 1 Clinical	Wuxi Apptec Co Ltd, Guangdong Zhongsheng Pharmaceutical Co Ltd	Carcinoma, Non-Small-Cell Lung	Details
Immunomodulatory progenitor cell therapy (Celixir)		Phase 3 Clinical	Celixir	Endomyocardial Fibrosis; Cardiomyopathies	Details
Antibody-drug nanocell conjugates (EnGeneIC)	EGFR-EDV-RRM1; EGFR-EDV-PLK; EGFR-EDV-Dox	Phase 1 Clinical	Engeneic	Glioblastoma	Details
Humanized anti-EGFR monoclonal antibody (Shanghai Henlius Biotech)	HLX-07	Phase 2 Clinical	Shanghai Henlius Biotech Co Ltd	Squamous Cell Carcinoma of Head and Neck; Neoplasms	Details
Sirotinib Maleate	XZP-5491	Phase 1 Clinical	Shandong Xuanzhu Pharmaceutical Technology Co Ltd	Stomach Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung	Details
Cetuximab I-131 (Pacific Meinuoke)		Clinical	Jiangsu Pacific-Meinuoke Bio-Pharmaceutical Co Ltd	Colorectal Neoplasms	Details
Panitumumab-IRDye800CW (Stanford University)		Phase 2 Clinical	Stanford University	Brain Neoplasms	Details
Cimaglermin alfa	CGF-2	Phase 1 Clinical	Ludwig Institute For Cancer Research	Heart Failure	Details
Humanized anti-EGFR monoclonal antibody (Hualan Biological Engineering/Henan shengming biotechnology)		Phase 1 Clinical	Hualan Genetic Engineering Co Ltd, Henan Shengming Biotechnology Research Institute Co Ltd	Colorectal Neoplasms	Details
ABY-029	ABY-029	Phase 1 Clinical	Dartmouth College, Affibody, Li-Cor Bioscience	Glioma	Details
DBPR-112	DBPR-112	Phase 1 Clinical	National Health Research Institutes	Head and Neck Neoplasms; Lung Neoplasms	Details
普维替尼		Phase 1 Clinical	Suzhou Teligene Ltd	Neoplasms	Details
Cetuximab biosimilar (Shanghai Henlius Biotech)	HLX-05	Phase 1 Clinical	Shanghai Henlius Biotech Co Ltd	Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms	Details
Recombinant human anti-EGFR mAb (Serum Biotechnology)	SY-101	Phase 2 Clinical	Institute Of Bioengineering Chinese Academy Of Military Medical Sciences, Shanghai Sailun Biological Technology Co Ltd	Colorectal Neoplasms	Details
BDTX-189	BDTX-189	Phase 2 Clinical	Black Diamond Therapeutics	Neoplasms	Details
Recombinant chimeric anti-EGFR monoclonal antibody (Zhejiang Xinwei Shengke Biotechnology)		Phase 1 Clinical	Zhejiang Xinweishengke Biotechnology Co Ltd	Esophageal Neoplasms	Details
Cetuximab biosimilar (Kelun Group)	KLA140; KL-A140	Phase 3 Clinical	Sichuan Kelun Pharmaceutical Co Ltd	Colorectal Neoplasms	Details
Tesevatinib	KD-019; KD-020; XL-647; EXEL-7647	Phase 3 Clinical	Exelixis Inc	Glioblastoma; Breast Neoplasms; Brain Neoplasms; Polycystic Kidney, Autosomal Dominant; Brain metastases; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Polycystic Kidney, Autosomal Recessive	Details
TQB3456	TQB-3456	Phase 1 Clinical	Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd, Lianyungang Runzhong Pharmaceutical Co Ltd, Beijing Sailintai Medicine Technology Co Ltd	Carcinoma, Non-Small-Cell Lung	Details
SPH1188-11	SPH1188-11	Phase 1 Clinical	Shanghai Pharmaceuticals Holding Co Ltd	Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung	Details
GC-1118A	GC-1118; GC-1118A	Phase 2 Clinical	Korean Green Cross Corp	Stomach Neoplasms; Glioblastoma; Colorectal Neoplasms; Neoplasm Metastasis	Details
Epitinib Succinate	HMPL-813	Phase 1 Clinical	Hutchison Medipharma Ltd	Solid tumours; Glioblastoma; Carcinoma, Non-Small-Cell Lung	Details
ASP-0598	ASP-0598	Phase 2 Clinical	Auration Biotech, Astellas Pharma Inc	Ear Diseases; Tympanic Membrane Perforation	Details
QL1203	QL-1203	Phase 3 Clinical	Qilu Pharmaceutical Co Ltd	Colorectal Neoplasms	Details
Varlitinib Ditosylate	QBT-01; ARRY-543; SPS-4370; ASLAN-001; ARRY-334543	Phase 3 Clinical	Array Biopharma	Biliary Tract Neoplasms; Neoplasms; Pancreatic Neoplasms; Bile Duct Neoplasms	Details
M-1231	M-1231	Phase 1 Clinical	Emd Serono Research & Development Institute Inc	Solid tumours; Esophageal Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
AZD-3759	AZD-3759	Phase 3 Clinical	Astrazeneca Plc	Brain metastases; Carcinoma, Non-Small-Cell Lung	Details
Poziotinib	NOV1201; HM-78136; HM-78136B; NOV-120101	Phase 2 Clinical	Hanmi Pharmaceutical Co Ltd	Solid tumours; Head and Neck Neoplasms; Stomach Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Glioma; Carcinoma, Non-Small-Cell Lung	Details
TAS-6417	CLN-081; TAS-6417	Phase 2 Clinical	Taiho Pharmaceutical Co Ltd	Carcinoma, Non-Small-Cell Lung	Details
Lazertinib	GNS-1480; JNJ-1937; YH-25448; JNJ-73841937	Phase 3 Clinical	Genosco	Carcinoma, Non-Small-Cell Lung	Details
TY-9591	TY-9591	Phase 1 Clinical	Zhejiang Tongkang Medicine Co Ltd	Carcinoma, Non-Small-Cell Lung	Details
Recombinant anti-InE monoclonal antibody		Phase 1 Clinical	Dingfu Biotarget	Solid tumours	Details
AP-32788	TAK-788; AP-32788	Phase 3 Clinical	Takeda Pharmaceutical Co Ltd, Ariad Pharmaceuticals Inc, Millennium Pharmaceuticals Inc	Kidney Diseases; Hepatic Insufficiency; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
ES-072	ES-072	Phase 1 Clinical	Zhejiang Bosheng Pharmaceutical Co Ltd	Carcinoma, Non-Small-Cell Lung	Details
FCN-411	FCN-411	Phase 1 Clinical	Shanghai Fosun Industry Co Ltd	Carcinoma, Non-Small-Cell Lung	Details
Anti-EGFR CAR-T cell therapy (Beijing Pregene)		Phase 2 Clinical	Shenzhen Prekin Biopharmaceutical Co Ltd	Colorectal Neoplasms	Details
ASK-120067	ASK-120067	Phase 3 Clinical	Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences, Jiangsu Aosaikang Pharmaceutical Co Ltd, Guangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences	Carcinoma, Non-Small-Cell Lung	Details
Recombinant anti-EGFR chimeric monoclonal antibody (Shanghai CP Guojian)	CPGJ-602; 602; CPGJ602; CPGJ 602	Phase 2 Clinical	Shanghai Cp Guojian Pharmaceutical Co Ltd	Colorectal Neoplasms	Details
Selatinib Ditosilate	QLNC-120	Phase 2 Clinical	Qilu Antibiotics (Linyi) Pharmaceutical Co Ltd, Qilu Pharmaceutical Co Ltd	Stomach Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
SKLB-1028	SKLB-1028	Phase 3 Clinical	Sichuan University, CSPC Pharmaceutical Group Ltd	Leukemia, Myeloid, Acute	Details
Recombinant human anti-EGFR mAB (Genrix Bio)	GR-1401; UBP-1215	Phase 1 Clinical	Shanghai Zhonghe Medicine Technology Co Ltd, Bioex Therapeutics	Head and Neck Neoplasms; Solid tumours; Esophageal Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
Allitinib Tosylate	AST-6; ALS-1306; AST-1306	Phase 2 Clinical	Shanghai Allist Pharmaceutical Technology Co Ltd	Breast Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
Betatinib	TL-512	Phase 1 Clinical	Aspedia Llc, Suzhou Teligene Ltd	Carcinoma, Non-Small-Cell Lung	Details
Recombinant chimeric anti-EGFR monoclonal antibody (Qilu Pharmaceutical)	QL-1105	Phase 1 Clinical	Qilu Pharmaceutical Co Ltd	Solid tumours	Details
Cetuximab biosimilar (AMPO Biotechnology)		Phase 3 Clinical	Foshan Ampze Biomedicine Co Ltd	Colorectal Neoplasms	Details
TQ-B3395	TQ-B3395; TQ-B-3395	Phase 1 Clinical	Beijing Sailintai Medicine Technology Co Ltd, Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd	Esophageal Neoplasms; Breast Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung	Details
Cetuximab biosimilar (Shanghai Zhangjiang Biotechnology)	STI-001; CMAB-009	Phase 3 Clinical	Shanghai Zhangjiang Biotechnology Co Ltd	Colorectal Neoplasms	Details
LR-004	LR-004; SYN-004	Phase 1 Clinical	Xingmeng Biotechnology (Beijing) Co Ltd, Lonn Ryonn Pharma Ltd	Solid tumours; Lymphoma, Large B-Cell, Diffuse; Colorectal Neoplasms	Details
Simotinib Hydrochloride	AL-6802; SIM-6802	Phase 1 Clinical	Jiangsu Xiansheng Pharmaceutical Co Ltd, Advenchen Laboratories	Colonic Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
Mefatinib		Phase 3 Clinical	Suzhou Maitai Bio-Technology Co Ltd	Solid tumours; Carcinoma, Non-Small-Cell Lung	Details
CK-101	CK-101; RX-518	Phase 3 Clinical	Suzhou Neupharma Co Ltd	Lung Diseases; Lung Neoplasms; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung	Details
Yinlitinib		Phase 1 Clinical	Hec Pharm Co Ltd	Solid tumours	Details
BPI-15086	BPI-15000; BPI-15086	Phase 1 Clinical	Betta Pharmaceuticals Co Ltd	Carcinoma, Non-Small-Cell Lung	Details
Cetuximab biosimilar (Guilin Sanjin)	CDP-1	Phase 1 Clinical	Guilin Sanjin Pharmaceutical Co Ltd, Dragonboat Biopharmaceutical	Solid tumours; Colorectal Neoplasms	Details
JRF-103	JRF103; JRF-103	Phase 2 Clinical	Shenzhen Jinrui Foundation Biotechnology Co Ltd	Solid tumours	Details
BPI-7711	BPI-7711	Phase 3 Clinical	Betapharma (Shanghai) Co Ltd	Carcinoma, Non-Small-Cell Lung	Details
Depatuxizumab mafodotin	ABT-414; ABT-414/806	Phase 3 Clinical	Abbvie Inc	Glioblastoma; Gliosarcoma; Carcinoma, Squamous Cell; Glioma; Carcinoma, Non-Small-Cell Lung	Details
Hemay-020	Hemay-020	Phase 1 Clinical	Tianjin Hemei Pharmaceutical Technology Co Ltd, Hainan General Sanyang Pharmaceutical Co Ltd	Solid tumours; Head and Neck Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
SCT-200	SCT-200	Phase 2 Clinical	Shenzhou Cell Engineering Co Ltd	Ovarian Neoplasms; Biliary Tract Neoplasms; Solid tumours; Head and Neck Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Carcinoma; Squamous Cell Carcinoma of Head and Neck; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Colorectal Neoplasms; Esophageal Squamous Cell Carcinoma; Gallbladder Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung	Details
HA121-28	HA121-28	Phase 2 Clinical	Cspc Pharmaceutical Technology (Shijiazhuang) Co Ltd	Biliary Tract Neoplasms; Solid tumours; Esophageal Neoplasms; Medullary thyroid cancer (MTC); Bile Duct Neoplasms	Details
[89Zr]Panitumumab (University of Alabama at Birmingham)		Phase 2 Clinical	University Of Alabama At Birmingham	Colonic Neoplasms	Details
MRG003	MRG-003	Phase 2 Clinical	Shanghai Miracogen Inc	Head and Neck Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms; Bile Duct Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
Sapitinib	AZD-8931	Phase 2 Clinical	Astrazeneca Pharmaceutical Co Ltd	Solid tumours; Esophageal Neoplasms; Stomach Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Neoplasm Metastasis	Details
MCLA-158	MCLA-158	Phase 1 Clinical	Merus	Colorectal Neoplasms	Details
Amivantamab	JNJ-61186372; JNJ-372	Phase 3 Clinical	Janssen Global Services Llc, Genmab	Carcinoma, Non-Small-Cell Lung	Details
MCLA-129	MCLA-129	Phase 1 Clinical	Merus	Solid tumours	Details
Larotinib Mesylate	Z-650	Phase 3 Clinical	Guangdong Dongyangguang Pharmaceutical Co Ltd	Solid tumours; Esophageal Neoplasms; Pancreatic Neoplasms; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma	Details
Nazartinib	EGF-816; EGFRmut-TKI EGF816	Phase 2 Clinical	Novartis Pharma Ag	Triple Negative Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma	Details
Oritinib Mesylate	SH-1028	Phase 3 Clinical	Nanjing Sanhome Pharmaceutical Co Ltd	Solid tumours; Carcinoma, Non-Small-Cell Lung	Details
AVID-100	AVID-100	Phase 2 Clinical	Formation Biologics	Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Breast Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung	Details
Kenaitinib	MED-1007; ML-007	Phase 2 Clinical	Jiangsu Maidu Pharmaceutical R & D Co Ltd	Carcinoma, Non-Small-Cell Lung	Details

English Name

Research Code

Research Phase

Company

Indications

Clinical Trials

JMT101

JMT-101

Phase 1 Clinical

Shanghai Jinmante Biological Technology Co Ltd

Carcinoma, Non-Small-Cell Lung

Details

BBT-176

Phase 2 Clinical

Bridge Biotherapeutics

Carcinoma, Non-Small-Cell Lung

Details

Durvalumab/Gefitinib

Phase 2 Clinical

Medimmune

Carcinoma, Non-Small-Cell Lung

Details

Cetuximab biosimilar (Enzene Biosciences)

Clinical

Enzene Biosciences

Carcinoma, Squamous Cell

Details

Neptinib Di-P-methylbenzenesulfonate

Phase 1 Clinical

Shenzhen Neptune Pharmaceutical Technology Research Institute Co Ltd

Stomach Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung

Details

Pirotinib Hydrochloride

KBP-5209

Phase 2 Clinical

Shandong Xuanzhu Pharmaceutical Technology Co Ltd

Neoplasms; Breast Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung

Details

YZJ-0318 Maleate

Phase 1 Clinical

Shanghai Haiyan, Yangtze River Pharmaceutical Group Jiangsu Haici Biological Pharmaceut Co Ltd

Carcinoma, Non-Small-Cell Lung

Details

Recombinant anti-EGFR chimeric antibody (Harbin Pharmaceutical)

Phase 1 Clinical

Harbin Pharmaceutical Group Holding Co Ltd

Colorectal Neoplasms

Details

BCA-101

Phase 1 Clinical

Bicara Therapeutics

Anus Neoplasms; Squamous Cell Carcinoma of Head and Neck; Thyroid Carcinoma, Anaplastic; Triple Negative Breast Neoplasms; Pancreatic Neoplasms; Glioblastoma; Carcinoma, Ovarian Epithelial; Neoplasms; Uveal melanoma; Chordoma; Colorectal Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Hepatocellular

Details

EGFRvIII-CAR

Phase 1 Clinical

Duke University Medical Center

Glioblastoma

Details

Recombinant anti-EGFR monoclonal antibody (Humanwell Healthcare)

Phase 1 Clinical

Humanwell Healthcare (Group) Co Ltd

Colorectal Neoplasms

Details

C-005

Phase 1 Clinical

Nanjing Galaxy Biopharma Co Ltd

Carcinoma, Non-Small-Cell Lung

Details

Anti-EGFR CAR-T cell therapy (Cellular Biomedicine Group)

Phase 2 Clinical

Cellular Biomedicine (Shanghai) Co Ltd, People'S Liberation Army General Hospital Military Service

Neoplasms

Details

Anti-CD3/anti-EGFR -activated T cells (Barbara Ann Karmanos Cancer Institute)

Phase 2 Clinical

Barbara Ann Karmanos Cancer Institute, University Of Virginia

Glioblastoma; Pancreatic Neoplasms

Details

Anti-EGFR-IL-dox (Swiss Group for Clinical Cancer Research)

Phase 2 Clinical

Schweizerische Arbeitsgemeinschaft Für Klinische Krebsforschung

Breast Neoplasms

Details

BB-101 (Blue Blood Biotech/National Cheng Kung University)

BB-101

Phase 1 Clinical

National Cheng Kung University, Blue Blood Biotech

Diabetic Foot

Details

NRC-2694

NRC-2694; NRC-2694A; NRC-2694-A

Phase 2 Clinical

Natco

Carcinoma, Squamous Cell

Details

Autologous EGFR-CAR T cells (Bio-gene)

Phase 1 Clinical

Sun Yat-Sen University, Guangzhou Baiji Gene Technology Co Ltd

Carcinoma, Non-Small-Cell Lung

Details

Tarloxotinib Bromide

PR-610; TH-4000; SN-33999

Phase 2 Clinical

Threshold

Neoplasms; Carcinoma, Non-Small-Cell Lung

Details

C225-ILS-DOX

C225-ILs-dox

Phase 2 Clinical

Universitaetsspitals Basel

Breast Neoplasms

Details

E-EDV-D682

PNU-15982; E-EDV-D682; EGFR-EDV-PNU-15982

Phase 2 Clinical

Engeneic

Pancreatic Neoplasms

Details

MicroRNA encapsulated nanocells (EnGeneIC)

Phase 2 Clinical

Engeneic

Mesothelioma

Details

AFM-24

Phase 2 Clinical

Affimed

Neoplasms

Details

Cetuximab biosimilar (R-Pharm)

RPH-002

Phase 3 Clinical

R-Pharm

Head and Neck Neoplasms; Pancreatic Neoplasms

Details

14C-labeled poziotinib

Phase 1 Clinical

Spectrum Pharmaceuticals

Neoplasms

Details

Cetuximab biosimilar (AlphaMab)

KN-005

Phase 3 Clinical

Suzhou Alphamab Co Ltd

Head and Neck Neoplasms; Anus Neoplasms; Urinary Bladder Neoplasms; Colorectal Neoplasms

Details

AMX-3009 Maleate

AMX-3009; AMX3009马来酸

Phase 1 Clinical

Anrun Medicine Technology (Suzhou) Co Ltd

Solid tumours; Stomach Neoplasms; Pancreatic Neoplasms; Breast Neoplasms

Details

4-1BBz CD19-Her2tG (Seattle Children's Hospital)

Phase 1 Clinical

Seattle Children'S Hospital

Neoplasms

Details

Cetuximab biobetter (Glycotope)

GT-MAB-5.2-GEX

Phase 2 Clinical

Glycotope

Head and Neck Neoplasms; Carcinoma, Renal Cell; Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung

Details

Anti-EGFR-bispecific antibody armed activated T-cell therapy (Memorial Sloan Kettering Cancer Center)

Phase 1 Clinical

Memorial Sloan Kettering Cancer Center

Pancreatic Neoplasms

Details

HER-1 vaccine (Center of Molecular Immunology)

HER1-ECD; HER1-VSSP; HER-1-ECD-VSSP

Phase 2 Clinical

Center Of Molecular Immunology

Neoplasms

Details

Double-deleted Vaccinia Virus Plus CD/ SMR

JX-929; vvDD-CDSR

Phase 1 Clinical

Sillajen

Liver Neoplasms; Squamous Cell Carcinoma of Head and Neck; Pancreatic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Melanoma

Details

SGT-210

Phase 1 Clinical

Sol Gel Technologies Pte Ltd

Keratosis

Details

Futuximab/Modotuximab

Sym-004; 992-and-1024

Phase 3 Clinical

Symphogen

Carcinoma; Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms

Details

Pemlimogene merolisbac (Aduro Biotech/Jannsen Biotech)

ADU-214; JNJ-64041757

Phase 2 Clinical

Aduro Biotech

Ovarian Neoplasms; Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung

Details

MM-151

Phase 2 Clinical

Merrimack

Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung

Details

EMB-01

Phase 2 Clinical

Shanghai Epimab Biotherapeutics, Inc

Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis

Details

D2C7-based immunotoxins (Duke University)

D2C7-IT; scds-D2C7 -PE38KDEL; D2C7-(scdsFv)-PE38 KDEL

Phase 1 Clinical

Istari Oncology, Duke University

Glioma

Details

PB-357

Phase 1 Clinical

Pfizer Inc

Neoplasms

Details

Losatuxizumab vedotin

ABBV221; ABBV-221

Phase 1 Clinical

Abbvie Inc

Neoplasms

Details

Nimotuzumab biosimilar (El Kendi Pharmaceuticals Manufacturing)

Phase 3 Clinical

El Kendi Pharmaceuticals

Uterine Cervical Neoplasms

Details

TQB3804

TQB-3804

Phase 1 Clinical

Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd

Solid tumours; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung

Details

Recombinant anti-EGFR monoclonal antibody- DUO5 conjugate

Phase 1 Clinical

Zhejiang Hisun Pharmaceutical Co Ltd, Zhejiang Zhaohua Biomedicine Co Ltd

Neoplasms

Details

SI-B001

Phase 1 Clinical

Sichuan Baili Pharmaceutical Co Ltd

Carcinoma; Neoplasms, Glandular and Epithelial

Details

BB-401

Phase 2 Clinical

Benitec Biopharma

Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck

Details

WSD-0922

WSD0922; WSD-0922

Phase 1 Clinical

Wayshine Biopharm

Glioblastoma; Glioma

Details

Doxitinib mesylate

Phase 2 Clinical

Henan Real Biotechnology Co Ltd

Carcinoma, Non-Small-Cell Lung

Details

Cetuximab biobetter (Mabtech/Sorrento)

STI-001

Phase 3 Clinical

Taizhou Maibo Taike Biotechnology Co Ltd, Shanghai Biomabs Pharmaceuticals Co Ltd

Colorectal Neoplasms

Details

Anti-EGFR CAR T-cell therapy (Seattle Children's Hospital)

EGFR-806

Phase 1 Clinical

Seattle Children'S Hospital

Central Nervous System Neoplasms

Details

Epertinib

S-222611

Phase 2 Clinical

Shionogi & Co Ltd

Neoplasms

Details

BEBT-109

Phase 1 Clinical

Guangzhou Bibet Medical Technology Co Ltd

Carcinoma, Non-Small-Cell Lung

Details

KSP-QRH-E3-IRDye800

Phase 1 Clinical

University Of Michigan

Cholangiocarcinoma

Details

YK-029A

Phase 1 Clinical

Hainan Yuekang Biomedicine Co Ltd

Carcinoma, Non-Small-Cell Lung

Details

Entinostat/Erlotinib Hydrochloride

Phase 2 Clinical

Colorado State University Foundation, Syndax

Carcinoma, Non-Small-Cell Lung

Details

MP-0274

DARPin-41; SPA-28; CME-114; CME-115; CME-118; CME-119; MP-0274

Phase 1 Clinical

Molecular Partners Ag

Neoplasms

Details

DZD-9008

Phase 2 Clinical

Dizal (Jiangsu) Pharmaceutical Co Ltd

Leukemia; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Lymphoma; Lymphoma, Non-Hodgkin; Carcinoma, Non-Small-Cell Lung

Details

ZSP0391

ZSP-0391

Phase 1 Clinical

Wuxi Apptec Co Ltd, Guangdong Zhongsheng Pharmaceutical Co Ltd

Carcinoma, Non-Small-Cell Lung

Details

Immunomodulatory progenitor cell therapy (Celixir)

Phase 3 Clinical

Celixir

Endomyocardial Fibrosis; Cardiomyopathies

Details

Antibody-drug nanocell conjugates (EnGeneIC)

EGFR-EDV-RRM1; EGFR-EDV-PLK; EGFR-EDV-Dox

Phase 1 Clinical

Engeneic

Glioblastoma

Details

Humanized anti-EGFR monoclonal antibody (Shanghai Henlius Biotech)

HLX-07

Phase 2 Clinical

Shanghai Henlius Biotech Co Ltd

Squamous Cell Carcinoma of Head and Neck; Neoplasms

Details

Sirotinib Maleate

XZP-5491

Phase 1 Clinical

Shandong Xuanzhu Pharmaceutical Technology Co Ltd

Stomach Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung

Details

Cetuximab I-131 (Pacific Meinuoke)

Clinical

Jiangsu Pacific-Meinuoke Bio-Pharmaceutical Co Ltd

Colorectal Neoplasms

Details

Panitumumab-IRDye800CW (Stanford University)

Phase 2 Clinical

Stanford University

Brain Neoplasms

Details

Cimaglermin alfa

CGF-2

Phase 1 Clinical

Ludwig Institute For Cancer Research

Heart Failure

Details

Humanized anti-EGFR monoclonal antibody (Hualan Biological Engineering/Henan shengming biotechnology)

Phase 1 Clinical

Hualan Genetic Engineering Co Ltd, Henan Shengming Biotechnology Research Institute Co Ltd

Colorectal Neoplasms

Details

ABY-029

Phase 1 Clinical

Dartmouth College, Affibody, Li-Cor Bioscience

Glioma

Details

DBPR-112

Phase 1 Clinical

National Health Research Institutes

Head and Neck Neoplasms; Lung Neoplasms

Details

普维替尼

Phase 1 Clinical

Suzhou Teligene Ltd

Neoplasms

Details

Cetuximab biosimilar (Shanghai Henlius Biotech)

HLX-05

Phase 1 Clinical

Shanghai Henlius Biotech Co Ltd

Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms

Details

Recombinant human anti-EGFR mAb (Serum Biotechnology)

SY-101

Phase 2 Clinical

Institute Of Bioengineering Chinese Academy Of Military Medical Sciences, Shanghai Sailun Biological Technology Co Ltd

Colorectal Neoplasms

Details

BDTX-189

Phase 2 Clinical

Black Diamond Therapeutics

Neoplasms

Details

Recombinant chimeric anti-EGFR monoclonal antibody (Zhejiang Xinwei Shengke Biotechnology)

Phase 1 Clinical

Zhejiang Xinweishengke Biotechnology Co Ltd

Esophageal Neoplasms

Details

Cetuximab biosimilar (Kelun Group)

KLA140; KL-A140

Phase 3 Clinical

Sichuan Kelun Pharmaceutical Co Ltd

Colorectal Neoplasms

Details

Tesevatinib

KD-019; KD-020; XL-647; EXEL-7647

Phase 3 Clinical

Exelixis Inc

Glioblastoma; Breast Neoplasms; Brain Neoplasms; Polycystic Kidney, Autosomal Dominant; Brain metastases; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Polycystic Kidney, Autosomal Recessive

Details

TQB3456

TQB-3456

Phase 1 Clinical

Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd, Lianyungang Runzhong Pharmaceutical Co Ltd, Beijing Sailintai Medicine Technology Co Ltd

Carcinoma, Non-Small-Cell Lung

Details

SPH1188-11

Phase 1 Clinical

Shanghai Pharmaceuticals Holding Co Ltd

Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung

Details

GC-1118A

GC-1118; GC-1118A

Phase 2 Clinical

Korean Green Cross Corp

Stomach Neoplasms; Glioblastoma; Colorectal Neoplasms; Neoplasm Metastasis

Details

Epitinib Succinate

HMPL-813

Phase 1 Clinical

Hutchison Medipharma Ltd

Solid tumours; Glioblastoma; Carcinoma, Non-Small-Cell Lung

Details

ASP-0598

Phase 2 Clinical

Auration Biotech, Astellas Pharma Inc

Ear Diseases; Tympanic Membrane Perforation

Details

QL1203

QL-1203

Phase 3 Clinical

Qilu Pharmaceutical Co Ltd

Colorectal Neoplasms

Details

Varlitinib Ditosylate

QBT-01; ARRY-543; SPS-4370; ASLAN-001; ARRY-334543

Phase 3 Clinical

Array Biopharma

Biliary Tract Neoplasms; Neoplasms; Pancreatic Neoplasms; Bile Duct Neoplasms

Details

M-1231

Phase 1 Clinical

Emd Serono Research & Development Institute Inc

Solid tumours; Esophageal Neoplasms; Carcinoma, Non-Small-Cell Lung

Details

AZD-3759

Phase 3 Clinical

Astrazeneca Plc

Brain metastases; Carcinoma, Non-Small-Cell Lung

Details

Poziotinib

NOV1201; HM-78136; HM-78136B; NOV-120101

Phase 2 Clinical

Hanmi Pharmaceutical Co Ltd

Solid tumours; Head and Neck Neoplasms; Stomach Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Glioma; Carcinoma, Non-Small-Cell Lung

Details

TAS-6417

CLN-081; TAS-6417

Phase 2 Clinical

Taiho Pharmaceutical Co Ltd

Carcinoma, Non-Small-Cell Lung

Details

Lazertinib

GNS-1480; JNJ-1937; YH-25448; JNJ-73841937

Phase 3 Clinical

Genosco

Carcinoma, Non-Small-Cell Lung

Details

TY-9591

Phase 1 Clinical

Zhejiang Tongkang Medicine Co Ltd

Carcinoma, Non-Small-Cell Lung

Details

Recombinant anti-InE monoclonal antibody

Phase 1 Clinical

Dingfu Biotarget

Solid tumours

Details

AP-32788

TAK-788; AP-32788

Phase 3 Clinical

Takeda Pharmaceutical Co Ltd, Ariad Pharmaceuticals Inc, Millennium Pharmaceuticals Inc

Kidney Diseases; Hepatic Insufficiency; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung

Details

ES-072

Phase 1 Clinical

Zhejiang Bosheng Pharmaceutical Co Ltd

Carcinoma, Non-Small-Cell Lung

Details

FCN-411

Phase 1 Clinical

Shanghai Fosun Industry Co Ltd

Carcinoma, Non-Small-Cell Lung

Details

Anti-EGFR CAR-T cell therapy (Beijing Pregene)

Phase 2 Clinical

Shenzhen Prekin Biopharmaceutical Co Ltd

Colorectal Neoplasms

Details

ASK-120067

Phase 3 Clinical

Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences, Jiangsu Aosaikang Pharmaceutical Co Ltd, Guangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences

Carcinoma, Non-Small-Cell Lung

Details

Recombinant anti-EGFR chimeric monoclonal antibody (Shanghai CP Guojian)

CPGJ-602; 602; CPGJ602; CPGJ 602

Phase 2 Clinical

Shanghai Cp Guojian Pharmaceutical Co Ltd

Colorectal Neoplasms

Details

Selatinib Ditosilate

QLNC-120

Phase 2 Clinical

Qilu Antibiotics (Linyi) Pharmaceutical Co Ltd, Qilu Pharmaceutical Co Ltd

Stomach Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung

Details

SKLB-1028

Phase 3 Clinical

Sichuan University, CSPC Pharmaceutical Group Ltd

Leukemia, Myeloid, Acute

Details

Recombinant human anti-EGFR mAB (Genrix Bio)

GR-1401; UBP-1215

Phase 1 Clinical

Shanghai Zhonghe Medicine Technology Co Ltd, Bioex Therapeutics

Head and Neck Neoplasms; Solid tumours; Esophageal Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung

Details

Allitinib Tosylate

AST-6; ALS-1306; AST-1306

Phase 2 Clinical

Shanghai Allist Pharmaceutical Technology Co Ltd

Breast Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung

Details

Betatinib

TL-512

Phase 1 Clinical

Aspedia Llc, Suzhou Teligene Ltd

Carcinoma, Non-Small-Cell Lung

Details

Recombinant chimeric anti-EGFR monoclonal antibody (Qilu Pharmaceutical)

QL-1105

Phase 1 Clinical

Qilu Pharmaceutical Co Ltd

Solid tumours

Details

Cetuximab biosimilar (AMPO Biotechnology)

Phase 3 Clinical

Foshan Ampze Biomedicine Co Ltd

Colorectal Neoplasms

Details

TQ-B3395

TQ-B3395; TQ-B-3395

Phase 1 Clinical

Beijing Sailintai Medicine Technology Co Ltd, Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd

Esophageal Neoplasms; Breast Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung

Details

Cetuximab biosimilar (Shanghai Zhangjiang Biotechnology)

STI-001; CMAB-009

Phase 3 Clinical

Shanghai Zhangjiang Biotechnology Co Ltd

Colorectal Neoplasms

Details

LR-004

LR-004; SYN-004

Phase 1 Clinical

Xingmeng Biotechnology (Beijing) Co Ltd, Lonn Ryonn Pharma Ltd

Solid tumours; Lymphoma, Large B-Cell, Diffuse; Colorectal Neoplasms

Details

Simotinib Hydrochloride

AL-6802; SIM-6802

Phase 1 Clinical

Jiangsu Xiansheng Pharmaceutical Co Ltd, Advenchen Laboratories

Colonic Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung

Details

Mefatinib

Phase 3 Clinical

Suzhou Maitai Bio-Technology Co Ltd

Solid tumours; Carcinoma, Non-Small-Cell Lung

Details

CK-101

CK-101; RX-518

Phase 3 Clinical

Suzhou Neupharma Co Ltd

Lung Diseases; Lung Neoplasms; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung

Details

Yinlitinib

Phase 1 Clinical

Hec Pharm Co Ltd

Solid tumours

Details

BPI-15086

BPI-15000; BPI-15086

Phase 1 Clinical

Betta Pharmaceuticals Co Ltd

Carcinoma, Non-Small-Cell Lung

Details

Cetuximab biosimilar (Guilin Sanjin)

CDP-1

Phase 1 Clinical

Guilin Sanjin Pharmaceutical Co Ltd, Dragonboat Biopharmaceutical

Solid tumours; Colorectal Neoplasms

Details

JRF-103

JRF103; JRF-103

Phase 2 Clinical

Shenzhen Jinrui Foundation Biotechnology Co Ltd

Solid tumours

Details

BPI-7711

Phase 3 Clinical

Betapharma (Shanghai) Co Ltd

Carcinoma, Non-Small-Cell Lung

Details

Depatuxizumab mafodotin

ABT-414; ABT-414/806

Phase 3 Clinical

Abbvie Inc

Glioblastoma; Gliosarcoma; Carcinoma, Squamous Cell; Glioma; Carcinoma, Non-Small-Cell Lung

Details

Hemay-020

Phase 1 Clinical

Tianjin Hemei Pharmaceutical Technology Co Ltd, Hainan General Sanyang Pharmaceutical Co Ltd

Solid tumours; Head and Neck Neoplasms; Carcinoma, Non-Small-Cell Lung

Details

SCT-200

Phase 2 Clinical

Shenzhou Cell Engineering Co Ltd

Ovarian Neoplasms; Biliary Tract Neoplasms; Solid tumours; Head and Neck Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Carcinoma; Squamous Cell Carcinoma of Head and Neck; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Colorectal Neoplasms; Esophageal Squamous Cell Carcinoma; Gallbladder Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung

Details

HA121-28

Phase 2 Clinical

Cspc Pharmaceutical Technology (Shijiazhuang) Co Ltd

Biliary Tract Neoplasms; Solid tumours; Esophageal Neoplasms; Medullary thyroid cancer (MTC); Bile Duct Neoplasms

Details

[89Zr]Panitumumab (University of Alabama at Birmingham)

Phase 2 Clinical

University Of Alabama At Birmingham

Colonic Neoplasms

Details

MRG003

MRG-003

Phase 2 Clinical

Shanghai Miracogen Inc

Head and Neck Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms; Bile Duct Neoplasms; Carcinoma, Non-Small-Cell Lung

Details

Sapitinib

AZD-8931

Phase 2 Clinical

Astrazeneca Pharmaceutical Co Ltd

Solid tumours; Esophageal Neoplasms; Stomach Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Neoplasm Metastasis

Details

MCLA-158

Phase 1 Clinical

Merus

Colorectal Neoplasms

Details

Amivantamab

JNJ-61186372; JNJ-372

Phase 3 Clinical

Janssen Global Services Llc, Genmab

Carcinoma, Non-Small-Cell Lung

Details

MCLA-129

Phase 1 Clinical

Merus

Solid tumours

Details

Larotinib Mesylate

Z-650

Phase 3 Clinical

Guangdong Dongyangguang Pharmaceutical Co Ltd

Solid tumours; Esophageal Neoplasms; Pancreatic Neoplasms; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma

Details

Nazartinib

EGF-816; EGFRmut-TKI EGF816

Phase 2 Clinical

Novartis Pharma Ag

Triple Negative Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma

Details

Oritinib Mesylate

SH-1028

Phase 3 Clinical

Nanjing Sanhome Pharmaceutical Co Ltd

Solid tumours; Carcinoma, Non-Small-Cell Lung

Details

AVID-100

Phase 2 Clinical

Formation Biologics

Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Breast Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung

Details

Kenaitinib

MED-1007; ML-007

Phase 2 Clinical

Jiangsu Maidu Pharmaceutical R & D Co Ltd

Carcinoma, Non-Small-Cell Lung

Details

Call us

North America: +1 800-810-0816 (Toll Free)

Asia & Pacific: +86 400-682-2521

order@acrobiosystems.com

Fax

+1 888-377-6111

Address

1 Innovation Way, Newark, DE 19711, USA

Products by Category

Recombinant proteins and more

Services

Pre-labeled proteins

Kits

Others

Hot Products

Supports on COVID-19 R&D

Others

Rhesus macaque EGF R Protein, His Tag

Comments (0)

Order Details

EGR-C52H1-50ug

EGR-C52H1-1mg (500ug × 2)

Promotion & Exhibitions

Drug Development Status

Datasheet & Documentation

Contact Us

Related Products

New Product Launch

Questions & Comments

Subscribe newsletter

Leave a message